Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lægeklinikken Hørsholm ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   0.0% 0.0% 5.7% 2.2% 3.8% 2.7% 13.6% 11.6%   Credit score (0-100)   0 0 40 64 51 59 17 21   Credit rating   N/A N/A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 605 1,630 1,208 1,295 0.0 0.0   EBITDA   0.0 0.0 286 616 94.5 82.3 0.0 0.0   EBIT   0.0 0.0 229 558 45.1 82.3 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 215.9 540.2 41.4 50.4 0.0 0.0   Net earnings   0.0 0.0 168.4 416.7 31.1 35.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 216 540 41.4 50.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 120 62.5 13.0 13.0 0.0 0.0   Shareholders equity total   0.0 0.0 208 625 656 691 651 651   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.2 125 0.0 0.0   Balance sheet total (assets)   0.0 0.0 1,448 1,713 1,302 1,616 651 651   Net Debt   0.0 0.0 -334 -376 -323 -310 -651 -651     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 605 1,630 1,208 1,295 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 169.5% -25.9% 7.2% -100.0% 0.0%   Employees   0 0 1 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 1,448 1,713 1,302 1,616 651 651   Balance sheet change%   0.0% 0.0% 0.0% 18.3% -24.0% 24.1% -59.7% 0.0%   Added value   0.0 0.0 286.4 615.8 102.6 82.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 62 -115 -99 0 -13 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 37.8% 34.2% 3.7% 6.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 16.2% 36.5% 5.2% 6.9% 0.0% 0.0%   ROI %   0.0% 0.0% 37.0% 68.2% 9.1% 13.7% 0.0% 0.0%   ROE %   0.0% 0.0% 80.8% 100.0% 4.9% 5.2% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 14.4% 36.5% 50.4% 42.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -116.6% -61.0% -341.8% -377.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 18.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 37,304.6% 81.1% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 1.2 2.0 1.4 1.5 0.0 0.0   Current Ratio   0.0 0.0 1.6 2.5 2.0 1.7 0.0 0.0   Cash and cash equivalent   0.0 0.0 334.1 375.7 323.4 435.4 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 514.3 997.1 643.2 678.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 286 308 51 41 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 286 308 47 41 0 0   EBIT / employee   0 0 229 279 23 41 0 0   Net earnings / employee   0 0 168 208 16 18 0 0